Institutions / RA Capital Management, L.P. / Move history
Back to RA Capital Management, L.P.

RA Capital Management, L.P.

Quarter-over-quarter position changes

53 changes

ActionCompanyQuarter ↓Δ sharesΔ %Held afterFlowImpact
Exited171757206Mar 31, 2026-3,365,523-100%0$743.41Mhigh
ExitedAvidity Biosciences, Inc.Mar 31, 2026-8,641,031-100%0$623.28Mhigh
NewSpyGlass Pharma, Inc.SGPMar 31, 2026+8,021,117New8,021,117$207.83Mhigh
NewZai Lab LimitedMar 31, 2026+5,707,262New5,707,262$107.35Mhigh
NewSarepta Therapeutics, Inc.Mar 31, 2026+3,902,596New3,902,596$84.92Mhigh
AddedDianthus Therapeutics, Inc.Mar 31, 2026+1,000,000+62%2,611,733$83.92Mhigh
ExitedArcellx, Inc.Mar 31, 2026-1,267,156-100%0$82.62Mhigh
ExitedBELITE BIO, INCBLTEMar 31, 2026-432,484-100%0$69.18Mhigh
AddedNuvalent, Inc.Mar 31, 2026+654,088+35%2,534,145$67.01Mhigh
AddedY95308105Mar 31, 2026+8,772,496+48%26,975,505$63.60Mhigh
New36322Q206Mar 31, 2026+2,399,310New2,399,310$62.14Mhigh
NewXencor IncMar 31, 2026+4,897,237New4,897,237$59.06Mhigh
AddedVAXCYTE, INC.Mar 31, 2026+750,000+7.0%11,474,599$43.58Mmedium
ExitedInvivyd, Inc.Mar 31, 2026-17,119,096-100%0$42.28Mmedium
NewCentury Therapeutics, Inc.IPSCMar 31, 2026+17,754,430New17,754,430$40.13Mmedium
AddedDisc Medicine, Inc.IRONMar 31, 2026+474,089+24%2,450,221$30.31Mmedium
NewMirum Pharmaceuticals, Inc.Mar 31, 2026+318,554New318,554$29.43Mmedium
NewBioAge Labs, Inc.BIOAMar 31, 2026+1,650,648New1,650,648$28.87Mmedium
NewAktis Oncology, Inc.AKTSMar 31, 2026+1,503,084New1,503,084$26.89Mmedium
NewALX Oncology Holdings Inc.Mar 31, 2026+13,011,849New13,011,849$26.09Mmedium
NewAclaris Therapeutics, Inc.Mar 31, 2026+6,804,072New6,804,072$25.52Mmedium
AddedSolid Biosciences Inc.SLDBMar 31, 2026+3,528,555+61%9,339,978$25.41Mmedium
NewTravere Therapeutics, Inc.Mar 31, 2026+746,841New746,841$22.19Mmedium
NewRelmada Therapeutics, Inc.Mar 31, 2026+2,947,369New2,947,369$20.51Mmedium
NewBRIGHT MINDS BIOSCIENCES INC.Mar 31, 2026+265,000New265,000$19.34Mmedium
NewSutro Biopharma, Inc.Mar 31, 2026+715,307New715,307$17.82Mmedium
NewAnteris Technologies Global Corp.Mar 31, 2026+3,000,000New3,000,000$16.65Mmedium
NewOnKure Therapeutics, Inc.Mar 31, 2026+3,998,333New3,998,333$16.55Mmedium
AddedDesign Therapeutics, Inc.DSGNMar 31, 2026+1,511,592+103%2,972,973$16.08Mmedium
AddedAcumen Pharmaceuticals, Inc.Mar 31, 2026+6,060,606+41%20,992,669$14.30Mmedium
ExitedMedline Inc.Mar 31, 2026-335,000-100%0$14.07Mmedium
NewHelix Acquisition Corp. IIIMar 31, 2026+1,250,000New1,250,000$12.70Mmedium
NewAtrium Therapeutics, Inc.Mar 31, 2026+864,102New864,102$11.55Mmedium
TrimmedContineum Therapeutics, Inc.Mar 31, 2026-883,699-41%1,296,012$11.54Mmedium
AddedHinge Health, Inc.Mar 31, 2026+284,500+355%364,613$10.97Mmedium
NewKaryopharm Therapeutics Inc.Mar 31, 2026+1,917,354New1,917,354$10.68Mmedium
AddedMINERALYS THERAPEUTICS INCMLYSMar 31, 2026+369,000+5.0%7,692,750$10.00Mmedium
AddedGeneDx Holdings Corp.Mar 31, 2026+151,843+262%209,887$9.75Mmedium
AddedInspire Medical Systems, Inc.Mar 31, 2026+183,699+129%325,663$9.48Mmedium
AddedWaystar Holding Corp.Mar 31, 2026+385,000+267%529,400$9.28Mmedium
NewCorvus Pharmaceuticals, Inc.Mar 31, 2026+450,000New450,000$6.58Mmedium
NewEquillium, Inc.Mar 31, 2026+3,096,336New3,096,336$6.19Mmedium
AddedBicara Therapeutics Inc.Mar 31, 2026+300,000+4.3%7,255,993$5.97Mmedium
Trimmed4D MOLECULAR THERAPEUTICS, INC.Mar 31, 2026-603,432-11%5,049,779$5.62Mmedium
NewMacroGenics, Inc.Mar 31, 2026+1,864,176New1,864,176$5.39Mmedium
NewMAPLIGHT THERAPEUTICS INCMPLTMar 31, 2026+248,294New248,294$5.05Mmedium
ExitedProgyny, Inc.Mar 31, 2026-96,628-100%0$2.48Mlow
ExitedN72482206Mar 31, 2026-43,976-100%0$2.08Mlow
ExitedORTHOPEDIATRICS CORPKIDSMar 31, 2026-109,959-100%0$1.95Mlow
ExitedHealth Catalyst, Inc.Mar 31, 2026-793,749-100%0$1.90Mlow
← PrevPage 1 of 2Next →